Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-07-18700CALL0 0145.18TRUE00
2025-07-18750CALL0 0149TRUE00
2025-07-18800CALL0 0136.77TRUE00
2025-07-18850CALL0 0125.29TRUE00
2025-07-18900CALL0 0114.46TRUE00
2025-07-18950CALL0 0109.74TRUE00
2025-07-181000CALL0 0104.36TRUE00
2025-07-181050CALL0 095.06TRUE00
2025-07-181100CALL0 086.2TRUE00
2025-07-181150CALL0 083.93TRUE00
2025-07-181200CALL0 075.64TRUE00
2025-07-181250CALL0 361.9TRUE00
2025-07-181300CALL0 064.11TRUE00
2025-07-181350CALL0 056.49TRUE00
2025-07-181400CALL0 12552.02TRUE00
2025-07-181450CALL0 049.92TRUE00
2025-07-1815022.6CALL0 10146.05TRUE00
2025-07-1815519.81CALL0 243.79TRUE00
2025-07-181600CALL0 242.43TRUE00
2025-07-1816512.61CALL10 1746.66TRUE4.110.48
2025-07-181705.6CALL0 35542.5TRUE00
2025-07-181756.5CALL0 11441.85FALSE00
2025-07-181805.5CALL0 540.6FALSE00
2025-07-181851.96CALL0 20438.15FALSE00
2025-07-181903.13CALL0 340.56FALSE00
2025-07-181951.95CALL0 043.8FALSE00
2025-07-182000.6CALL0 16148.01FALSE00
2025-07-182100CALL0 357.74FALSE00
2025-07-182200CALL0 167.28FALSE00
2025-07-182300.7CALL0 576.37FALSE00
2025-07-182400CALL0 384.81FALSE00
2025-07-18700PUT0 0218.53FALSE00
2025-07-18750PUT0 0203.54FALSE00
2025-07-18800PUT0 0189.55FALSE00
2025-07-18850PUT0 0176.4FALSE00
2025-07-18900PUT0 5164.01FALSE00
2025-07-18950PUT0 1152.26FALSE00
2025-07-181000PUT0 5141.09FALSE00
2025-07-181050.2PUT0 11694.93FALSE00
2025-07-181100PUT0 0120.82FALSE00
2025-07-181150PUT0 1110.96FALSE00
2025-07-181200PUT0 0101.97FALSE00
2025-07-181250PUT0 192.73FALSE00
2025-07-181300PUT0 184.21FALSE00
2025-07-181350PUT0 075.83FALSE00
2025-07-181400PUT0 20067.57FALSE00
2025-07-181451.1PUT0 159.72FALSE00
2025-07-181501.5PUT0 752.42FALSE00
2025-07-181552.61PUT0 3645.87FALSE00
2025-07-181602.87PUT0 4442.91FALSE00
2025-07-181654.93PUT0 2441.3FALSE00
2025-07-181705.67PUT0 21040.8FALSE00
2025-07-1817510.3PUT0 040.19TRUE00
2025-07-181800PUT0 038.49TRUE00
2025-07-181850PUT0 037.2TRUE00
2025-07-181900PUT0 034.06TRUE00
2025-07-181950PUT0 030.72TRUE00
2025-07-182000PUT0 056.65TRUE00
2025-07-182100PUT0 071.81TRUE00
2025-07-182200PUT0 083.01TRUE00
2025-07-182300PUT0 093.3TRUE00
2025-07-182400PUT0 0102.86TRUE00
2025-08-151200CALL0 051.34TRUE00
2025-08-151250CALL0 049.59TRUE00
2025-08-151300CALL0 046.98TRUE00
2025-08-151350CALL0 045.28TRUE00
2025-08-151400CALL0 044.81TRUE00
2025-08-151450CALL0 044.54TRUE00
2025-08-151500CALL0 044.09TRUE00
2025-08-1515524.18CALL0 143.58TRUE00
2025-08-151600CALL0 043.57TRUE00
2025-08-151650CALL0 043.36TRUE00
2025-08-1517013.15CALL0 242.52TRUE00
2025-08-1517510.15CALL1 141.68FALSE-0.35-0.03
2025-08-151807.86CALL0 441.39FALSE00
2025-08-151859.5CALL0 1040.28FALSE00
2025-08-151907.05CALL0 139.51FALSE00
2025-08-151950CALL0 038.77FALSE00
2025-08-152004.35CALL0 1239.02FALSE00
2025-08-152100CALL0 040.74FALSE00
2025-08-152200CALL0 045.84FALSE00
2025-08-152300CALL0 051.01FALSE00
2025-08-152400CALL0 056.13FALSE00
2025-08-152500CALL0 061.39FALSE00
2025-08-152600CALL0 066.34FALSE00
2025-08-151200PUT0 068.08FALSE00
2025-08-151250PUT0 062.28FALSE00
2025-08-151300PUT0 057.19FALSE00
2025-08-151350PUT0 052.37FALSE00
2025-08-151400PUT0 048.17FALSE00
2025-08-151450PUT0 046.81FALSE00
2025-08-151500PUT0 043.74FALSE00
2025-08-151554PUT0 142.19FALSE00
2025-08-151604.43PUT0 1041.98FALSE00
2025-08-151655.78PUT0 1041.87FALSE00
2025-08-151700PUT0 041.37FALSE00
2025-08-151750PUT0 040.39TRUE00
2025-08-151800PUT0 039.88TRUE00
2025-08-151850PUT0 038.23TRUE00
2025-08-151900PUT0 037.74TRUE00
2025-08-151950PUT0 035.98TRUE00
2025-08-152000PUT0 035.72TRUE00
2025-08-152100PUT0 032.2TRUE00
2025-08-152200PUT0 057.67TRUE00
2025-08-152300PUT0 064.75TRUE00
2025-08-152400PUT0 071.33TRUE00
2025-08-152500PUT0 077.48TRUE00
2025-08-152600PUT0 083.27TRUE00
2025-09-19750CALL0 069.4TRUE00
2025-09-19800CALL0 071.97TRUE00
2025-09-19850CALL0 069.29TRUE00
2025-09-19900CALL0 062.09TRUE00
2025-09-19950CALL0 061.43TRUE00
2025-09-191000CALL0 056.82TRUE00
2025-09-191050CALL0 053.82TRUE00
2025-09-191100CALL0 052.81TRUE00
2025-09-191150CALL0 050.98TRUE00
2025-09-191200CALL0 049.3TRUE00
2025-09-191250CALL0 049.58TRUE00
2025-09-191300CALL0 049.4TRUE00
2025-09-191350CALL0 048.54TRUE00
2025-09-191400CALL0 047.71TRUE00
2025-09-191450CALL0 047.74TRUE00
2025-09-191500CALL0 147.42TRUE00
2025-09-191550CALL0 047.19TRUE00
2025-09-191600CALL0 046.96TRUE00
2025-09-191650CALL0 046.89TRUE00
2025-09-191700CALL0 046.02TRUE00
2025-09-1917515.82CALL0 445.47FALSE00
2025-09-191800CALL0 245.06FALSE00
2025-09-1918512.1CALL0 044.52FALSE00
2025-09-191907CALL0 144.64FALSE00
2025-09-191958.35CALL0 243.42FALSE00
2025-09-192009.6CALL0 57343.11FALSE00
2025-09-192104.59CALL0 141.87FALSE00
2025-09-192200CALL0 041.14FALSE00
2025-09-192302.4CALL0 142.58FALSE00
2025-09-192401.5CALL0 50145.41FALSE00
2025-09-192500.8CALL0 148.2FALSE00
2025-09-192600.35CALL0 151.41FALSE00
2025-09-19750PUT0 0104.29FALSE00
2025-09-19800PUT0 097.17FALSE00
2025-09-19850PUT0 090.48FALSE00
2025-09-19900PUT0 084.17FALSE00
2025-09-19950PUT0 078.2FALSE00
2025-09-191000PUT0 072.87FALSE00
2025-09-191050PUT0 067.76FALSE00
2025-09-191100PUT0 063.13FALSE00
2025-09-191150PUT0 058.9FALSE00
2025-09-191200PUT0 054.97FALSE00
2025-09-191250PUT0 051.91FALSE00
2025-09-191300PUT0 049.23FALSE00
2025-09-191352.6PUT0 148.2FALSE00
2025-09-191403.3PUT0 146.02FALSE00
2025-09-191450PUT0 046.13FALSE00
2025-09-191500PUT0 045.03FALSE00
2025-09-191557.3PUT0 245.9FALSE00
2025-09-191600PUT0 045.89FALSE00
2025-09-191650PUT0 045.33FALSE00
2025-09-1917012.48PUT0 045.21FALSE00
2025-09-1917515.95PUT0 244.28TRUE00
2025-09-191800PUT0 043.92TRUE00
2025-09-191850PUT0 043.38TRUE00
2025-09-191900PUT0 042.51TRUE00
2025-09-191950PUT0 041.95TRUE00
2025-09-192000PUT0 042.18TRUE00
2025-09-192100PUT0 039.08TRUE00
2025-09-192200PUT0 038.28TRUE00
2025-09-192300PUT0 036.83TRUE00
2025-09-192400PUT0 057.29TRUE00
2025-09-192500PUT0 062.19TRUE00
2025-09-192600PUT0 066.81TRUE00
2025-10-17750CALL0 065.55TRUE00
2025-10-17800CALL0 062.64TRUE00
2025-10-17850CALL0 059.59TRUE00
2025-10-17900CALL0 056.48TRUE00
2025-10-17950CALL0 053.34TRUE00
2025-10-171000CALL0 050.21TRUE00
2025-10-171050CALL0 048.19TRUE00
2025-10-171100CALL0 049.03TRUE00
2025-10-171150CALL0 048.98TRUE00
2025-10-171200CALL0 049.24TRUE00
2025-10-171250CALL0 048.81TRUE00
2025-10-171300CALL0 048.77TRUE00
2025-10-171350CALL0 048.38TRUE00
2025-10-171400CALL0 047.71TRUE00
2025-10-171450CALL0 047.55TRUE00
2025-10-171500CALL0 047.03TRUE00
2025-10-1715529.75CALL0 746.05TRUE00
2025-10-171600CALL0 045.7TRUE00
2025-10-171650CALL0 045.43TRUE00
2025-10-1717021.5CALL0 645.22TRUE00
2025-10-171750CALL0 044.68FALSE00
2025-10-1718013.8CALL0 344.36FALSE00
2025-10-171850CALL0 143.6FALSE00
2025-10-171900CALL0 043.21FALSE00
2025-10-171950CALL0 042.68FALSE00
2025-10-172009CALL0 142.16FALSE00
2025-10-172100CALL0 041FALSE00
2025-10-172200CALL0 240.12FALSE00
2025-10-172300CALL0 240.17FALSE00
2025-10-172400CALL0 140.27FALSE00
2025-10-172501.4CALL0 142.52FALSE00
2025-10-172601.1CALL0 144.65FALSE00
2025-10-17750PUT0 090.79FALSE00
2025-10-17800PUT0 084.61FALSE00
2025-10-17850PUT0 078.81FALSE00
2025-10-17900PUT0 073.34FALSE00
2025-10-17950PUT0 068.49FALSE00
2025-10-171000PUT0 064.15FALSE00
2025-10-171050PUT0 160.23FALSE00
2025-10-171100PUT0 156.63FALSE00
2025-10-171150PUT0 053.28FALSE00
2025-10-171200PUT0 050.5FALSE00
2025-10-171250PUT0 248.26FALSE00
2025-10-171300PUT0 247.09FALSE00
2025-10-171356PUT0 146.88FALSE00
2025-10-171400PUT0 046.33FALSE00
2025-10-171450PUT0 046.25FALSE00
2025-10-171500PUT0 046.2FALSE00
2025-10-171550PUT0 044.97FALSE00
2025-10-171600PUT0 044.81FALSE00
2025-10-171650PUT0 044.42FALSE00
2025-10-171700PUT0 044.2FALSE00
2025-10-171750PUT0 144.03TRUE00
2025-10-171800PUT0 043.5TRUE00
2025-10-171850PUT0 042.77TRUE00
2025-10-171900PUT0 042.24TRUE00
2025-10-171950PUT0 041.51TRUE00
2025-10-172000PUT0 041.3TRUE00
2025-10-172100PUT0 040.54TRUE00
2025-10-172200PUT0 037.87TRUE00
2025-10-172300PUT0 036.74TRUE00
2025-10-172400PUT0 051.59TRUE00
2025-10-172500PUT0 055.97TRUE00
2025-10-172600PUT0 060.09TRUE00
2025-12-19600CALL0 068.77TRUE00
2025-12-19650CALL0 063.75TRUE00
2025-12-19700CALL0 062.81TRUE00
2025-12-19750CALL0 161.09TRUE00
2025-12-19800CALL0 058.97TRUE00
2025-12-19850CALL0 057.47TRUE00
2025-12-19900CALL0 056.9TRUE00
2025-12-19950CALL0 056.17TRUE00
2025-12-191000CALL0 054.86TRUE00
2025-12-191050CALL0 054.63TRUE00
2025-12-191100CALL0 054.64TRUE00
2025-12-191150CALL0 053.97TRUE00
2025-12-191200CALL0 052.16TRUE00
2025-12-191250CALL0 3851.96TRUE00
2025-12-191300CALL0 152.65TRUE00
2025-12-191350CALL0 151.56TRUE00
2025-12-191400CALL0 350.88TRUE00
2025-12-1914545.54CALL0 250.65TRUE00
2025-12-1915037.5CALL0 250.38TRUE00
2025-12-191550CALL0 050.07TRUE00
2025-12-191600CALL0 6649.49TRUE00
2025-12-191650CALL0 049.24TRUE00
2025-12-191700CALL0 8148.73TRUE00
2025-12-191750CALL0 048.32FALSE00
2025-12-191800CALL0 1248.2FALSE00
2025-12-191850CALL0 1547.97FALSE00
2025-12-1919020.8CALL0 347.41FALSE00
2025-12-191950CALL0 6046.97FALSE00
2025-12-192000CALL0 5546.55FALSE00
2025-12-192100CALL0 1045.91FALSE00
2025-12-192200CALL0 4545.06FALSE00
2025-12-192300CALL0 044.07FALSE00
2025-12-192400CALL0 243.28FALSE00
2025-12-192500CALL0 242.33FALSE00
2025-12-192600CALL0 041.49FALSE00
2025-12-19600PUT0 090.5FALSE00
2025-12-19650PUT0 184.68FALSE00
2025-12-19700PUT0 079.3FALSE00
2025-12-19750PUT0 074.28FALSE00
2025-12-19800PUT0 2069.88FALSE00
2025-12-19850PUT0 165.98FALSE00
2025-12-19900PUT0 2162.48FALSE00
2025-12-19950PUT0 159.3FALSE00
2025-12-191000PUT0 156.75FALSE00
2025-12-191050PUT0 154.83FALSE00
2025-12-191100PUT0 152.08FALSE00
2025-12-191150PUT0 052.3FALSE00
2025-12-191204.03PUT0 252.71FALSE00
2025-12-191250PUT0 152.02FALSE00
2025-12-191300PUT0 151.61FALSE00
2025-12-191350PUT0 150.9FALSE00
2025-12-191400PUT0 050.09FALSE00
2025-12-191450PUT0 149.87FALSE00
2025-12-191500PUT0 049.46FALSE00
2025-12-191550PUT0 049.14FALSE00
2025-12-191600PUT0 049.23FALSE00
2025-12-191650PUT0 048.46FALSE00
2025-12-191700PUT0 048FALSE00
2025-12-191750PUT0 047.82TRUE00
2025-12-191800PUT0 047.49TRUE00
2025-12-191850PUT0 16447.13TRUE00
2025-12-191900PUT0 046.75TRUE00
2025-12-191950PUT0 046.14TRUE00
2025-12-192000PUT0 1645.72TRUE00
2025-12-192100PUT0 144.9TRUE00
2025-12-192200PUT0 243.74TRUE00
2025-12-192300PUT0 042.88TRUE00
2025-12-192400PUT0 141.4TRUE00
2025-12-192500PUT0 040.19TRUE00
2025-12-192600PUT0 051.53TRUE00
2026-01-16750CALL0 058.97TRUE00
2026-01-16800CALL0 057.27TRUE00
2026-01-16850CALL0 056.6TRUE00
2026-01-16900CALL0 055.84TRUE00
2026-01-16950CALL0 054.98TRUE00
2026-01-161000CALL0 054.37TRUE00
2026-01-161050CALL0 054.74TRUE00
2026-01-161100CALL0 054.37TRUE00
2026-01-161150CALL0 053.72TRUE00
2026-01-161200CALL0 052.86TRUE00
2026-01-161250CALL0 052.7TRUE00
2026-01-161300CALL0 053.18TRUE00
2026-01-161350CALL0 052.83TRUE00
2026-01-161400CALL0 052.11TRUE00
2026-01-161450CALL0 050.69TRUE00
2026-01-161500CALL0 850.47TRUE00
2026-01-161550CALL0 050.23TRUE00
2026-01-1616035.98CALL0 649.98TRUE00
2026-01-1616524.85CALL0 2149.31TRUE00
2026-01-161700CALL0 748.96TRUE00
2026-01-1617525.75CALL0 148.22FALSE00
2026-01-161800CALL0 548.48FALSE00
2026-01-1618520.2CALL0 3848.06FALSE00
2026-01-1619022CALL0 247.76FALSE00
2026-01-161950CALL0 047FALSE00
2026-01-162000CALL0 246.87FALSE00
2026-01-1621016.16CALL0 346.07FALSE00
2026-01-1622011.94CALL0 145.66FALSE00
2026-01-1623010.3CALL0 245.14FALSE00
2026-01-162407.2CALL0 144.46FALSE00
2026-01-162506.75CALL0 144.29FALSE00
2026-01-162600CALL0 043.83FALSE00
2026-01-16750PUT0 069.79FALSE00
2026-01-16800PUT0 065.65FALSE00
2026-01-16850PUT0 062.23FALSE00
2026-01-16900PUT0 058.91FALSE00
2026-01-16950PUT0 056.5FALSE00
2026-01-161000PUT0 054.88FALSE00
2026-01-161050PUT0 054.79FALSE00
2026-01-161100PUT0 052.18FALSE00
2026-01-161150PUT0 052.19FALSE00
2026-01-161200PUT0 051.53FALSE00
2026-01-161250PUT0 051.44FALSE00
2026-01-161300PUT0 551.11FALSE00
2026-01-161350PUT0 2751.37FALSE00
2026-01-161400PUT0 1951.01FALSE00
2026-01-161450PUT0 1450.4FALSE00
2026-01-1615018.6PUT0 149.93FALSE00
2026-01-161550PUT0 049.35FALSE00
2026-01-161600PUT0 048.87FALSE00
2026-01-161650PUT0 1648.5FALSE00
2026-01-161700PUT0 048.21FALSE00
2026-01-161750PUT0 047.81TRUE00
2026-01-161800PUT0 047.59TRUE00
2026-01-161850PUT0 047.18TRUE00
2026-01-161900PUT0 046.86TRUE00
2026-01-161950PUT0 046.45TRUE00
2026-01-162000PUT0 046.25TRUE00
2026-01-162100PUT0 045.12TRUE00
2026-01-162200PUT0 044.54TRUE00
2026-01-162300PUT0 044.08TRUE00
2026-01-162400PUT0 043.32TRUE00
2026-01-162500PUT0 042.3TRUE00
2026-01-162600PUT0 041.64TRUE00
2026-06-18800CALL0 057.98TRUE00
2026-06-18850CALL0 058.61TRUE00
2026-06-18900CALL0 057.41TRUE00
2026-06-18950CALL0 058.01TRUE00
2026-06-181000CALL0 056.09TRUE00
2026-06-181050CALL0 056.08TRUE00
2026-06-181100CALL0 056.27TRUE00
2026-06-181150CALL0 056.09TRUE00
2026-06-181200CALL0 054.88TRUE00
2026-06-181250CALL0 054.46TRUE00
2026-06-181300CALL0 054.13TRUE00
2026-06-181350CALL0 053.98TRUE00
2026-06-181400CALL0 1053.7TRUE00
2026-06-181450CALL0 053.86TRUE00
2026-06-181500CALL0 053.44TRUE00
2026-06-181550CALL0 052.58TRUE00
2026-06-1816049CALL0 252.41TRUE00
2026-06-1816538.61CALL0 252.07TRUE00
2026-06-181700CALL0 051.57TRUE00
2026-06-181750CALL0 051.69FALSE00
2026-06-181800CALL0 050.89FALSE00
2026-06-181850CALL0 050.71FALSE00
2026-06-181900CALL0 050.38FALSE00
2026-06-181950CALL0 050.29FALSE00
2026-06-182000CALL0 050.07FALSE00
2026-06-182100CALL0 049.24FALSE00
2026-06-182200CALL0 048.68FALSE00
2026-06-182300CALL0 048.4FALSE00
2026-06-182400CALL0 047.71FALSE00
2026-06-182500CALL0 047.31FALSE00
2026-06-182600CALL0 047.11FALSE00
2026-06-18800PUT0 056.74FALSE00
2026-06-18850PUT0 054.95FALSE00
2026-06-18900PUT0 055.52FALSE00
2026-06-18950PUT0 054.92FALSE00
2026-06-181000PUT0 054.65FALSE00
2026-06-181050PUT0 054.18FALSE00
2026-06-181100PUT0 053.78FALSE00
2026-06-181150PUT0 054.43FALSE00
2026-06-181200PUT0 054.03FALSE00
2026-06-181250PUT0 053.83FALSE00
2026-06-181300PUT0 252.41FALSE00
2026-06-181350PUT0 053.1FALSE00
2026-06-181400PUT0 053.46FALSE00
2026-06-181450PUT0 053.27FALSE00
2026-06-181500PUT0 052.87FALSE00
2026-06-1815522.5PUT0 152.04FALSE00
2026-06-181600PUT0 051.54FALSE00
2026-06-181650PUT0 051.44FALSE00
2026-06-181700PUT0 051.15FALSE00
2026-06-181750PUT0 050.77TRUE00
2026-06-181800PUT0 050.84TRUE00
2026-06-181850PUT0 050.06TRUE00
2026-06-181900PUT0 049.89TRUE00
2026-06-181950PUT0 049.56TRUE00
2026-06-182000PUT0 049.08TRUE00
2026-06-182100PUT0 048.43TRUE00
2026-06-182200PUT0 047.97TRUE00
2026-06-182300PUT0 047.73TRUE00
2026-06-182400PUT0 046.99TRUE00
2026-06-182500PUT0 046.45TRUE00
2026-06-1826090.48PUT0 26945.31TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm